USPTO backs Medtronic in patent infringement case against Axonics
The ruling from the US Patent and Trademark Office means that Axonics attempts to invalidate two Medtronic patents have failed, opening the way for Medtronic to sue.
22 March 2024
22 March 2024
The ruling from the US Patent and Trademark Office means that Axonics attempts to invalidate two Medtronic patents have failed, opening the way for Medtronic to sue.
The DynamX BTK System is designed for the treatment of narrowed or blocked vessels below the knee in patients with CLTI.
The NavDx tumour-tissue–modified HPV (TTMV) DNA blood test aims to detect HPV-driven head and neck cancer.
The CIARTIC Move is tailored for various surgical applications, including trauma, orthopaedic, and spine surgery.
The RemeOs magnesium alloy is designed for use in orthopaedic implants.
The companies will focus on next generation sequencing – the market of which has been under the spotlight in the past year.
The OSPREY trial for sleep apnoea treatment concluded early with positive outcomes.
The trial will enhance genetic testing and treatment personalisation for ovarian cancer in Canada.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.